ARTICLE | Clinical News
Actemra regulatory update
February 4, 2013 8:00 AM UTC
Roche disclosed in its 4Q12 earnings that it submitted applications for a subcutaneous formulation of tocilizumab to EMA and FDA to treat moderate to severe rheumatoid arthritis in December 2012. An I...